Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
Pharma Marketing News e-Newsletter | Subscribe | Pharma Marketing Online Discussion Forum
Reports | Resources/Links | Glossary | Case Studies | Surveys | Pharma Marketing Blog
Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy
| Also see Pharma Marketing News OpEd Pieces |
FDA Drug Watch Site Guidelines
Posted: May 9, 2005As reported in today's Wall Street Journal ("FDA Issues Guidelines For 'Drug Watch' Site, Details on Oversight Board") , the FDA issued a Gudiance (i.e., draft guidelines) last Friday on a "Drug Watch" web site for "Emerging Drug Safety Information."How about this idea:
Re-purpose The Homeland Security Advisory System color scale for use with drugs listed in the Drug Watch site and prohibit the use of DTC while a drug is the "high alert" red zone.
Wouldn't this make it easier for consumers to get an idea of the level of risk? Works for me - which is more than I can say for Homeland Security!